LifeScience Alley Conference & Expo | December 6, 2007

2007 Seminars

Breakfast Keynote

8:00 a.m. - 9:15 a.m.

Michael Joyner

Michael Joyner, MD

Deputy Director for Research

Mayo Clinic

“The Biomedical Future: Ideas vs. Infrastructure”

Michael Joyner, MD is Deputy Director for Research at Mayo Clinic. He is also a co-leader of Mayo’s Center for Translational Science Activities (CTSA), which focuses on speeding translation of scientific discoveries into treatments and therapies. In addition, Dr. Joyner is a Professor of Anesthesiology at Mayo Clinic and is the principal investigator on three NIH research grants. His research focuses on human cardiovascular control, specifically how the peripheral circulation and autonomic reflexes adapt and respond to mental and physical stress. He has a strong interest in helping to shape Minnesota’s life science infrastructure.

Podcasting and Webstreaming for Medical Marketing and Education

7:30 a.m. - 8:00 a.m.
2:15 p.m. - 2:45 p.m.

Capitalize on the latest Internet technologies to communicate your key messages to prospects, customers, distributors, and employees throughout the world.

	Use online video, audio, and graphic animations to increase the impact of your presentations
	Make your website come alive with motion, images, voices, and faces that show what you do
	Drive prospects and customers to your website through blogging and online promotional campaigns
	Keep in touch through simple, online subscription services.

Podcasting and webstreaming are quickly developing from buzzwords into mainstream media. Learn practical ways that your company can use these technologies for marketing and training on a global scale. From meetings and events, to online product launch campaigns, see how to use online media to quickly respond to changes in your marketplace. In just a half-hour we will show you how to put these powerful technologies to work for your company.

University of Minnesota Poster Session

9:15 a.m. - 12:30 p.m.

The University of Minnesota’s Institute for Engineering in Medicine (IEM — formerly The Biomedical Engineering Institute) and the BioTechnology Institute (BTI) are proud to present a joint graduate student poster session. The session will display up to 100 posters that showcase fascinating biomedical engineering and biotechnology related research currently taking place at the University of Minnesota. The juried poster session will be judged in the morning with award winners announced at the luncheon. The poster session provides an opportunity for graduate students to share their work and receive feedback fromindustry professionals. Research categories cover a wide variety of topics in biomedical engineering and biotechnology including, biocatalysis and biodegradation, biomaterials, biofuels, cellular bioengineering, computational techniques, devices and techniquesfor diagnosis, implantable/micro devices, metabolic engineering, systems biology, thermal therapies, and tissue engineering.

Innovation & Collaboration Center

9:15 a.m. - 12:30 p.m.

2:15 p.m. - 6:00 p.m.

New! The Collaboration and Innovation Center, sponsored by The Integra Group, has been developed with conference rooms for business collaboration opportunities, reservations can be made in advance on the conference website. The Bakken Museum will also conduct interactive scientific experiments onsite; view historical displays including a replica of Earl Bakken’s first pacemaker, Dr. Lillehei’s operating room headlamp, historical video, and much more. We encourage you to stop by to learn how you can become a mentor for young scientists.

New Technology Showcase

9:15 a.m. - 12:30 p.m.

2:15 p.m. - 6:00 p.m.

Here’s your chance to see leading edge technologies that are already shaping the future of our life science industry. Seven exciting companies have been selected to showcase their innovative products in a special display area. Three will present their new technologies at the luncheon general session. We encourage you to challenge the limits of your imagination!

New Technology Showcase Luncheon Presenters

New Technology Showcase Exhibitors

includes the three presenters listed at left, plus:

Gel-Del Technologies, Inc.
St. Paul, MN
VasoGraft™, small diameter artificial blood vessel

Kent Imaging
Calgary, Alberta
tissue viability imaging system

GlucoLight Corporation
Bethlehem, PA
SENTRIS-100, non-invasive glucose monitor

Mayo Clinic Medical Devices
Rochester, MN
Magnetic Resonance Elastography imaging technique

ScyFIX
Chanhassen, MN
ScyFIX 600 and 650, minimally invasive macular degeneration device

Nanogent Medical, Inc.
Victoria, MN
MST (Modified Surface Technology) drug & biological agent delivery system

The Tarilian Group
Welwyn Garden City, Hertfordshire (United Kingdom)
The Tarilian blood pressure measurement device

SPONSOR
TRACKS	Emerging Companies	Biologics & Pharmaceuticals	Research & Development	Clinical Studies	Regulatory Affairs & Market Access	Agricultural & Industrial Biotechnology	Leadership

SEMINAR

SESSION 1

9:45 a.m. - 11:00 a.m.

The Innovation Path:

Taking Your Science to the Market

Moderator: Jeffrey Saunders, JD, Partner, Dorsey & Whitney, LLP
Panelists: Doug Johnson, Director, Venture Center, University of Minnesota | Ian Smith, PhD, DSc, FRSC, OFS, Director General, National Research Council of Canada Institute for Biodiagnostics l James Grabek, President, Agricultural Solutions, Inc.

So you have a great idea for a science-based business? Now how do you get it out of the lab, off the coffee shop napkin and into practical application? Commercialization experts will help light the
way and provide valuable advice on how to avoid common pitfalls.

Why Medical Devices Need Biotech and Why Biotech Needs Medical Devices

Moderator/Panelist: Bonnie Baskin, PhD, President & CEO, AppTec Labs
Panelists: Don Kleinsek, CEO, GeriGene Medical Corporation | Nelson Scarborough, PhD, Group Director, Biologics R&D, Medtronic Spine and Biologics l Barb Potts, PhD, Principal Scientist, Quality, Genetech, Inc.

The makers of biologics need targeted and controlled delivery of their large molecules. Meet Minnesota’s device mega-cluster and the highly developed infrastructure that supports it! We are uniquely positioned to attract a growing biotech industry and lead the industry in Combination Products.

Stem Cell Research and Applications Today

Moderator: Michael Kallos, PhD, PEng, Principal Investigator, Canadian Stem Cell Network, University of Calgary

Panelists: Michael Haider, President & CEO, BioE, Inc. | Meri Firpo, PhD, Asst. Professor, University of Minnesota Stem Cell Institute and Department of Medicine

Stem cells derived from adults, cord blood and embryos are being studied. How will our region contribute to the science of discovery and applications? Leaders in the stem cell field will provide the
latest update of where they are and what to expect.

Choosing and Supporting the Right Physicians to Champion and Execute Your Clinical Trial

Moderator: Darin Lerew, PhD, Sr Clinical Manager, Medtronic Neuromodulation
Panelists: Kevin Nickels, President & CEO, Celleration, Inc. | Brian Olshansky, MD, Professor of Medicine, University of Iowa Hospitals

Selecting the right Study Investigators and Principal Investigators is vital when conducting clinical trials. How the team of investigators is selected and supported can make or break your study.

Adapting to FDA Requirement Changes and Keeping Innovation Alive

Moderator: Jeffrey Mirviss, Vice President Marketing, Boston Scientific Corporation
Panelists: Robert Klepinski, JD, Attorney, Fredrickson & Byron, PA | Mac McKeen, MBA, RAC, Director, Regulatory Affairs, St. Jude Medical, Atrial Fibrillation Division

Innovation needs to stay ahead of additional FDA clinical data requirements and post-market data requirements. Keep inspired and creative while taking care of those requirements.

Advanced Scenario: Planning for a Sustainable Renewable Energy Economy

Moderator: Amy Johnson, MPA, Senior Project Manager, BioBusiness Alliance of Minnesota
Commentators: Mary Jo Zidwick, PhD, Research Fellow, Biotechnology Development Center,

Cargill, Inc. | Mike Bull, Assistant Commissioner for Renewable Energy & Advanced Technologies, Minnesota Department of Commerce

The BioBusiness Alliance of Minnesota has partnered with innovative researchers at Sandia Labs on an exciting modeling project with applications in Renewable Energy and beyond. Hear how their work will change the way we approach Renewable Energy today and other bioscience business models in the future.

Managing Through Change: Leading In A Fast-Paced Environment

Moderator: Jim Hall, Vice President of Technical Operations, Lifecore Biomedical, Inc.
Panelists: Fred Parks, PhD, Chairman & CEO, Urologix, Inc. l Stacy Enxing Seng, President, Cardio Peripheral Division, ev3

Respected leaders of life science organizations in the region will share their insights on how they have successfully focused or refocused their mission. Specific areas that will be addressed
include setting expectations, merging cultures, getting buy-in, managing timelines, coordinating communications, and adapting business practices.

SPONSOR
TRACKS	Emerging Companies	Biologics & Pharmaceuticals	Research & Development	Clinical Studies	Regulatory Affairs & Market Access	Agricultural & Industrial Biotechnology	Leadership

SEMINAR

SESSION 2

11:15 a.m. - 12:30 p.m.

Starting Your Start-up: Learn from the Leaders

Moderator: Tom Martin, JD, Partner, Dorsey & Whitney, LLP
Panelists: Pete McNerney, Partner, Thomas McNerney & Partners | Mark Knudson, President & CEO, EnteroMedics, Inc.

Leaders experienced in shaping and growing new companies will discuss the most important phases in the growth of a scientific enterprise. Learn how best to manage—and balance—your R&D, Clinical, Regulatory, Reimbursement, Marketing & Sales functions.

Drug Discovery in the Region: Leveraging The Talents of Those Around Us

Moderator: Joel Green, JD, Partner, Lindquist & Vennum, PLLP
Panelists: Gunda Georg, PhD, Department Head, Medicinal Chemistry; Director, Institute for Therapeutics Discovery and Development, University of Minnesota, College of Pharmacy | David Land, President, Medisyn Technologies | Vickie O'Neill, Vice President, Drug Delivery, Upsher-Smith Laboratories, Inc.

Who knew that our region had such depth of knowledge in the area of medicinal chemistry and drug discovery? This session will shine a light on some of our “best kept secrets” and introduce you
to their revolutionary work that can be applied today.

Nanotechnology : Current Applications in Medical Devices

Moderator: Art Erdman, PhD, Professor & Director, Medical Device Center, University of Minnesota
Panelists: Bob Hoerr, MD, PhD, President & CEO, Nanocopoeia, Inc. | Robert Burrell, PhD, Canada Research Chair in Nanostructured Biomaterials, University of Alberta

Nanotechnology is already ubiquitous, and the possibilities for where this platform technology can go are endless! Learn from leaders in our region about how their exciting work is being applied to the field of medical devices today.

The Value of Collecting FDA and CMS Data Concurrently

Moderator: Mary Kay Kessinger Sobcinski, RN, Senior Principal Advisor, RCRI
Panelists: Karin Bolinger, Senior Reimbursement Manager, Medtronic, Inc., CRDM l Monica Schultz, Principal Advisor, RCRI

Look at the bigger picture. Designing a study to gather both clinical data and cost-effectiveness data can minimize costs and maximize results, while saving critical time.

510K Without Clinical Data: A Blessing or a Curse?

Moderator: Paula Skjefte, MBA, President & CEO, Waterford Consulting, Inc.
Panelists: Brent O’Connell, MD, MHSA, Chief Medical Officer, Argenta Reimbursement Advisors | Eric Simso, Vice President, Interventional Cardiology Marketing, Boston Scientific Corp.

Filing a 510K has been a quicker and easier way to get market access than starting with a PMA. But is this the right approach? In this time of greater demands for clinical data, what are the potential advantages and disadvantages of using the 510K approach?

Recent Advances in Plant Biotechnology:
Seeking Optimal
Crop Results for
Nutrition and
Bio Products

Moderator: Robert Elde, PhD, Dean of the College of Biological Sciences, University of Minnesota
Panelists: Michael Raab, PhD, CEO, Agrivada, Inc. l David Jessen, PhD, Head, Traits & Technology - Product Development, Syngenta Seeds, Inc.

Sometimes what an industry needs are tangible success stories that illustrate the benefits of new technologies. Hear scientific and industry leaders share real-life examples of new applications for
biotechnology in the areas of nutrition and bio-products.

Solving Unmet Global Health Needs: Altruism, Smart Business or Both?

Moderator: James Toscano, President, Minneapolis Heart Institute Foundation
Panelists: Jeff Chell, MD, CEO, National Marrow Donor Program | Joe McCullough, President International Division, St. Jude Medical

How do global organizations justify applying their resources to identifying and solving global health problems and why is it good business? In this session, we will take a refreshing look at how
healthcare organizations “Do Good” through for-profit and not-for-profit approaches.

Luncheon Keynote

12:30 p.m. - 2:15 p.m.

Paul Yock, MD

Director, Biodesign Program

Stanford University

"Creating a Commercialization Culture - A View From Silicon Valley's Life Science Cluster"

Paul Yock, MD is the Martha Meier Weiland Professor of Bioengineering and Cardiovascular Medicine at Stanford. He was the Founding Co-Chair of Stanford’s Department of Bioengineering and is Director of their highly respected program in Biodesign—a university-wide initiative for education and mentoring in technology innovation and translation. Dr. Yock is a Stanford cardiologist internationally known for his work in inventing, developing and testing new devices, including the Rapid Exchange balloon angioplasty system. He also founded Cardiovascular Imaging Systems, now a division of Boston Scientific.

SPONSOR
TRACKS	Emerging Companies	Biologics & Pharmaceuticals	Research & Development	Clinical Studies	Regulatory Affairs & Market Access	Agricultural & Industrial Biotechnology	Leadership

SEMINAR

SESSION 3

HOT TOPICS 2:45 p.m. - 4:00 p.m.

The Subtleties of Outsourcing:

Knowing When and How to Rely on the Expertise of Others

Moderator: Barbara Roth, Consultant Strategic Operations, ATIVA
Panelists: Howard Dittmer, Executive Vice President Engineering, Herbst LaZar Bell
Rich Nazarian, President & CEO, Minnetronix | Gregg Mosley, MS, President, Biotest Laboratories

A special talent of successful leaders is knowing when and how to identify the right contract partners. They exist in virtually every functional area and can liberate your company— be it large or small— to concentrate on its core competencies. Learn the tricks to better manage those relationships as you advance.

Consumer-Driven Health Care:

What’s the New Paradigm?

Moderator: David Melloh, JD, Partner, Lindquist & Vennum, PLLP
Panelists: Maureen Swan, Principal, The MedTrend Group l MaryAnn Stump, RN, Senior Vice President & Chief Innovation Office, Blue Cross Blue Shield of Minnesota

Savings Accounts, Electronic Medical Records, access to the Internet… all are precipitating a radical shift to consumer-driven health care. How will the industry respond and how will you manage this change in the work you do?

Bioinformatics: Computers for Cures

Moderator: Jeffrey Budd, PhD, Senior Staff Biostatistician, Beckman Coulter, Inc.

Panelists: Connie Delaney, PhD, RN, FAAN, FACMI Professor & Dean, School of Nursing, University of Minnesota, | Drew Flaada, Director, IBM/Mayo Collaboration, Life Sciences & Blue Gene Software Development | Eric Wieben, PhD, Director of Genomics Technology Center, Mayo Clinic

The genomic revolution will greatly expand our reliance on technology, particularly in bio-informatics. Experts within our community will, in this session, unveil where the field is going and how various technologies will compliment the Personalized Medicine approach to health care.

Devices vs. Drugs: Exploring New Treatment Technologies

Moderator: Judith Titcomb, JD, MPA, Principal, Pulse Innovation
Panelists: Rob Kieval, PhD, DVM, Executive Vice President and Chief Technology Officer, CVRx, Inc. l James Bullock, CEO, Atritech, Inc.

With continuing improvements in device capabilities, therapy options are changing. Drug therapies are now being facilitated by —or challenged by— advances in device technology.

Aging with Attitude: Health Care Demands of Baby Boomers

Moderator: MaryJo Kreitzer, PhD, RN, FAAN, Director, Center for Spirituality & Healing, University of Minnesota
Panelists: Bruce Batten, PhD, CEO/Co-Founder, Hylas, Inc. | Pennie Viggiano, MHA, MBA, System Director, Government and Special Populations, HealthEast Care System

What are new concerns that baby boomers will face and how will they push a change in health care delivery as they come through the system? As the “sandwich generation”, what are Baby
Boomer’s expectations for how their parents will be treated by physicians, hospitals and insurers?

Next Generation Combination Products

Moderator: Mark DuVal, President, DuVal & Associates, PA
Panelists: Joseph Smith, MD, PhD, Vice President, Microelectronic Technologies, Cordis Corporation, Johnson & Johnson | Darrel Untereker, PhD, Vice President, Corporate Research & Technology, Medtronic, Inc.

Beyond devices and drugs, the newest area of convergence involves implantable devices and sensors. Monitoring and diagnostics technologies offer a gateway into Personalized Medicine for the medical device industry. Hear about exciting new developments that are already happening in the industry.

Exciting, Inviting Science! Pop Culture and STEM education

Moderator: Cecily Sommers, President, Push Institute
Panelists: Timothy Jump, Director, Advanced Competitive Science, Benilde-St. Margaret’s School l Uta Sboto-Frankenstein, PhD, Institute for Biodiagnostics, National Research Council of Canada

In today’s world of Info-tainment, tomorrow’s scientists might be seduced from other career paths by enticing them with some fun: their kind of fun. What’s happening in the world of STEM education today?

Holiday Alley Chats Networking Reception

4:00 - 6:00 p.m.

SPONSORED BY:

Continue your networking at this festive event in the exhibit hall. Alley Chats are about Engaging life science industry members in order to collaborate in sharing resources. And what Better place to learn about the breadth and depth of resources within LifeScience Alley than in the Exhibit Hall where over 120 member organizations will be on display! Alley Chats sponsors will be giving away some great prizes so bring plenty of business cards for your chance to win. Mix and mingle while enjoying hors d’oeuvres and a cocktail (cash bar available) at this closing reception for the Conference & Expo.